Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO) "TREVO"

Completed

Phase 4 Results

Summary of Purpose

To determine the revascularization rate of the CE-marked Trevo device in large vessel occlusions in ischemic stroke patients. - Revascularization, defined as at least TICI 2a in the vascular territory treated at end of the neuro interventional procedure.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 July 2015.

1 Feb 2010 15 Mar 2010 1 Aug 2011 1 Nov 2011 1 Jul 2015 12 Feb 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • 1st Contact: Gary Walker, PhD Phone: 650-938-2100 ext 1736 Email: gwalker@concentric-medical.com 2nd Contact: Cindy Jahans, BSc Phone: 650-938-2100 ext 1729 Email: cjahans@concentric-medical.com

    gwalker@concentric-medical.com